NEW YORK (360Dx) – A point-of-care diagnostic test for Chagas disease, a risky infection threatening an increasing portion of the population, could be just what's needed in resource-poor regions where the infection is endemic.

The test could also help stem the infection's advance into other counties where people are being infected with increasing frequencies, said Steve Reed, CEO and founder of the Infectious Disease Research Institute, which collaborated with Seattle-based InBios International to develop the point-of-care test.